Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 200-203, 2013.
Artículo en Chino | WPRIM | ID: wpr-315777

RESUMEN

<p><b>OBJECTIVE</b>To evaluate the relationship between the Mandarin acceptable noise level (ANL) and the personality trait for normal-hearing adults.</p><p><b>METHODS</b>Eighty-five Mandarin speakers, aged from 21 to 27, participated in this study. ANL materials and the Eysenck Personality Questionnaire (EPQ) questionnaire were used to test the acceptable noise level and the personality trait for normal-hearing subjects. SPSS 17.0 was used to analyze the results.</p><p><b>RESULTS</b>ANL were (7.8 ± 2.9) dB in normal hearing participants. The P and N scores in EPQ were significantly correlated with ANL (r = 0.284 and 0.318, P < 0.01). No significant correlations were found between ANL and E and L scores (r = -0.036 and -.167, P > 0.05).</p><p><b>CONCLUSION</b>Listeners with higher ANL were more likely to be eccentric, hostile, aggressive, and instabe, no ANL differences were found in listeners who were different in introvert-extravert or lying.</p>


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Adulto Joven , Audiometría del Habla , Umbral Auditivo , Ruido , Personalidad
2.
Chinese Journal of Hepatology ; (12): 670-673, 2011.
Artículo en Chino | WPRIM | ID: wpr-330665

RESUMEN

<p><b>OBJECTIVE</b>To evaluate antiviral effects of Peg-IFNa-2a in patients with chronic hepatitis B.</p><p><b>METHODS</b>92 chronic hepatitis B patients were enrolled to receive the treatment with Peg-IFNa-2a 180 μg subcutaneous injection once weekly. The patients who did not get early response were divided into 3 groups: group 1, extend the treatment to 72 weeks; group 2, combined with nucleus(s)ide analogue (entecavir or adefovir) treatment; group 3, continue the treatment until 48 weeks. HBV DNA and quantitative HBsAg were assessed at baseline, week 12, 24, 36 and after 24 weeks follow-up.</p><p><b>RESULTS</b>Patients in group 1 had significantly higher SVR rate (78.3%) than patients in group 3 (38.1%, X2=7.33, P<0.05). The mean reduction of HBsAg in group 1 at 24 weeks of post-treatment follow up was higher than that in group 3 (t=2.11, P<0.05). In group 2 the mean reductions of HBV DNA at 24 weeks of post-treatment follow up were (3.9+/-1.1) log10 copy/ml and (3.7+/-1.3) log10 copy/ml respectively with combination of entecavir or adefovir, both of which were significantly higher than that in group 3(t=8.45 and 6.31, P<0.05); the SVR rates in the entecavir group and the adefovir group (83.3% and 85.7%, respectively) were significantly higher than that in group 3 (X2=8.20 and 7.78, P<0.05); the mean reductions of HBsAg in the entecavir group and the adefovir group [(0.8+/-0.5) log10 IU/ml and (0.9+/-0.3) log10 IU/ml, respectively ] were significantly greater than group 3[(0.4+/-0.3) log10 IU/ml, t=3.05 and 4.58, P<0.05]. The level of HBV DNA and C genotype were the main predictors of response.</p><p><b>CONCLUSION</b>Individualizing therapy by prolonging the duration of Peg-IFNa-2a treatment to 72 weeks or adding nucleoside analogues such as entecavir and adefovir in patients without early response may substantially increase the SVR rate and lead to the decrease of HBsAg.</p>


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adenina , Usos Terapéuticos , Antivirales , Usos Terapéuticos , Guanina , Usos Terapéuticos , Hepatitis B Crónica , Quimioterapia , Interferón-alfa , Usos Terapéuticos , Organofosfonatos , Usos Terapéuticos , Resultado del Tratamiento
3.
Chinese Journal of Preventive Medicine ; (12): 1000-1003, 2009.
Artículo en Chino | WPRIM | ID: wpr-316079

RESUMEN

<p><b>OBJECTIVE</b>To investigate the social health status of the HIV infected and their families in a high HIV/AIDS prevalence village in Hunan province and to examine the relations of the social health status, responses and social support.</p><p><b>METHODS</b>A total of 51 HIV infected persons (infected group), 49 family members of the infected (family member group) and 96 normal persons (control group) were surveyed by Social Health Measurement Scale-a sub-scale of Self-rated Health Measurement Scale (SRHMS), Social Support Assessment Scale (SSAS) and Trait Coping Style Questionnaire (TCSQ).</p><p><b>RESULTS</b>(1) In regard to the total scores of social health, responding style and social support, significant differences were found among the infected group, the group of family members and the control group (62.9 +/- 18.6, 79.8 +/- 18.0, 86.5 +/- 21.3, F = 18.16; 28.7 +/- 4.3, 27.2 +/- 5.4, 25.9 +/- 6.4, F = 5.21; 33.8 +/- 8.1, 41.0 +/- 6.6, 38.1 +/- 6.8, F = 13.23; P < 0.01). (2) Subjective care and support, the educational status, the marital status and support utilization were significant predictors to the social health status of the infected group (R(2) = 0.73, F = 27.78, P < 0.01). (3) Subjective support and negative responding style were significant predictors to the social health status of the group of family members (R(2) = 0.32, F = 12.35, P < 0.01).</p><p><b>CONCLUSION</b>The HIV infected and their families have more negative responding style, make less use of social support and hold a inferior social health status. It's necessary to exert psychological intervention targeting at these population group.</p>


Asunto(s)
Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Estudios de Casos y Controles , China , Familia , Psicología , Infecciones por VIH , Psicología , Estado de Salud , Muestreo , Apoyo Social , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA